AG00IBRY

68-35-9 | Sulfadiazine

Chemical structure of Sulfadiazine, CAS 68-35-9
AG00IBRY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 68-35-9
Catalog Number AG00IBRY(AGN-PC-0WAF2O)
Chemical Name Sulfadiazine
EC Number 200-685-8
IUPAC Name 4-amino-N-pyrimidin-2-ylbenzenesulfonamide
InChI InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)
InChI Key SEEPANYCNGTZFQ-UHFFFAOYSA-N
MDL Number MFCD00006065
Molecular Formula C10H10N4O2S
Molecular Weight 250.2770
SMILES O=S(C1=CC=C(N)C=C1)(NC2=NC=CC=N2)=O
UNII 0N7609K889
Synonyms
Sulfadiazine, Sulfadiazine, Zinc, Sulfazin, Sulfazine, Sulphadiazine, Zinc Sulfadiazine, sulfadiazine, Sulphadiazine, 68-35-9, Sulfapyrimidine, Sulfadiazin, Sulfazine, Sulfadiazene, Liquadiazine, Sulfapyrimidin, Adiazin, Adiazine, Debenal, Pyrimal, 2-Sulfanilamidopyrimidine, Cremodiazine, Spofadrizine, Theradiazine, Cremotres, Deltazina, Diazolone, Eskadiazine, Microsulfon, Neotrizine, Palatrize, Piridisir, Quadetts, Quadramoid, Sanodiazine, Sterazine, Sulfatryl, Sulfolex, Sulfonsol, Terfonyl, Trifonamide, Truozine, Diazin, Diazyl, Neazine, Pirimal, Sulfose, Trisem, Sulfanilamidopyrimidine, Honey diazine, Lipo-Levazine, Tri-Sulfameth, Triple Sulfas, Coco-Diazine, Lipo-Diazine, Metha-Meridiazine, Sulfadiazinum, Diazovit, Sulfadiazina, Sulphadiazine E, Sulfapirimidin, Di-Azo-Mul, Thi-Di-Mer, 2-Sulfanilylaminopyrimidine, Codiazine, Silvadene, Pecta-diazine, suspension, Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, CocoDiazine, Solfadiazina [DCIT], RP 2616, 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide, Pyrimidine, 2-sulfanilamido-, 2-Sulfanilamidopyrimidin, Sulfapyrimidin [German], 2-Sulfapyrimidine, Sulfonamides Duplex, Sulfadiazinum [INN-Latin], Sulfadiazina [INN-Spanish], 4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE, Zinc Sulfadiazine, N(1)-2-pyrimidylsulfanilamide, N(1)-2-pyrimidinylsulfanilamide, 2-Sulfanilamidopyrimidin [German], S.N. 112, 4-amino-N-pyrimidin-2-ylbenzenesulfonamide, A 306, A-306 (VAN), N(sup 1)-2-Pyrimidinylsulfanilamide, MFCD00006065, Thermazene, N1-2-Pyrimidinylsulfanilamide, Sildaflo, CHEBI:9328, Sulfanilamide, N(sup 1)-2-pyrimidinyl-, N(sup1)-2-Pyrimidylsulfanilamide, Sulfanilamide, N1-2(1H)-pyrimidinylidene-, 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide, 4-amino-N-pyrimidin-2-yl-benzenesulfonamide, N1-(Pyrimidin-2-yl)sulfanilamide, Sulfanilamide, N1-2-pyrimidinyl-, UNII-0N7609K889, A-306, N(sup1)-2-Pyrimidinylsulfanilamide, EINECS 200-685-8, NSC 35600, 4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide, CHEMBL439, N1-2-Pyrimidylsulfanilamide, BRN 0235192, C10H10N4O2S, Triple sulfa, 4-Amino-N-2-pyrimidinyl-benzenesulfonamide, AI3-01047, S. N. 112, SEEPANYCNGTZFQ-UHFFFAOYSA-N, N(1)-(2-Pyrimidinyl)sulfanilamide, NSC35600, CAS-68-35-9, NCGC00016305-01, Solfadiazina, 0N7609K889, [(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine, NSC117870, Pecta-Diazine, SMR000059113, Sulfadiazine (TN), N-(2-Pyrimidinyl)sulfanilamide, Sulfadiazine [USAN:INN:JAN], rBPI21 & Sulfa, SR-01000002973, SSD, 2-Sulfanilamido-pyrimidine, CRL-8131 & Sulfadiazine, Sulfadiazine (JAN/USP/INN), Sulfadiazine,(S), Trisulfapyrimidine, oral suspension, Sulfadiazine [USP:INN:BAN:JAN], DRG-0214, Prestwick_428, Spectrum_000986, Sulfadiazina Reig Jofre, Sulfacombin (Salt/Mix), AC1L1JUR, Prestwick0_000023, Prestwick1_000023, Prestwick2_000023, Prestwick3_000023, Spectrum2_001319, Spectrum3_001362, Spectrum4_000342, Spectrum5_000992, Epitope ID:140083, AC1Q51XM, AC1Q6W1E, Sulfadiazine, >=99.0%, DSSTox_CID_24130, DSSTox_RID_80105, DSSTox_GSID_44130, Oprea1_081078, SCHEMBL24176, BSPBio_000085, BSPBio_002884, KBioGR_000743, KBioSS_001466, 5-25-10-00067 (Beilstein Handbook Reference), MLS000069423, MLS006011457, DivK1c_000543, SPECTRUM1500546, SPBio_001417, SPBio_002006, BPBio1_000095, WLN: T6N CNJ BMSWR DZ, DTXSID7044130, CTK7D7930, HMS501L05, KBio1_000543, KBio2_001466, KBio2_004034, KBio2_006602, KBio3_002104, NINDS_000543, HMS1568E07, HMS1921A13, HMS2090P09, HMS2092I15, HMS2095E07, HMS2235D19, HMS3371L19, HMS3655I10, HMS3712E07, Pharmakon1600-01500546, ZINC120319, ALBB-014888, BCP12140, HY-B0273, Tox21_110360, BBL013169, BDBM50166571, CCG-39257, NSC-35600, NSC757324, Recombinant bactericidal/permeability-increasing protein & Sulfadiazine, s1770, SBB007604, SBB057674, STK317797, 2-(p-Aminobenzenesulfonamido)pyrimidin, AKOS000119073, CS-2263, DB00359, KS-1144, MCULE-4577338719, NE10425, NSC-757324, RP17586, 2-(4-Aminobenzenesulfonamido)pyrimidine, 4-amino-N-2-pyrimidylbenzenesulfonamide, IDI1_000543, N1-2(1H)-pyrimidinylidene-sulfanilamide, NCGC00016305-02, NCGC00016305-03, NCGC00016305-04, NCGC00016305-05, NCGC00016305-06, NCGC00016305-10, NCGC00023291-03, NCGC00023291-04, SULFADIAZINE (TRISULFAPYRIMIDINES), 2-(4-Aminobenzenesulfonylamino)pyrimidine, AC-26817, AK321973, H458, ST059447, Sulfanilamide, N1-2-pyrimidinyl- (8CI), ZB004097, Mixture of sulfadiazine, and sulfamethazine, SBI-0051520.P003, AB2000282, LS-147838, 4-[[(Pyrimidin-2-yl)amino]sulfonyl]aniline, 4-Amino-N-2-pyrimidinyl- benzenesulfonamide, AB00052095, Benzenesulfonamide,4-amino-N-2-pyrimidinyl-, FT-0674741, R3929, S0579, ST51006797, SW196657-3, TL80073596, 4-amino-N-(2-pyrimidinyl) benzenesulfonamide, 4-Amino-n-(2-pyrimidinyl)benzene-sulfonamide, 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide #, 68S359, C07658, D00587, Trisulfapyrimidine, oral suspension (Salt/Mix), AB00052095-13, AB00052095-14, AB00052095_15, AB00052095_16, Benzenesulfonamide, 4-amino-N-(2-pyrimidinyl)-, Sulfadiazine, VETRANAL(TM), analytical standard, Q-201759, SR-01000002973-2, SR-01000002973-3, BRD-K32273377-001-05-4, BRD-K32273377-001-09-6, I01-15838, F1657-1720, I14-110269, Sulfadiazine, certified reference material, TraceCERT(R), Z271004844, Sulfadiazine, European Pharmacopoeia (EP) Reference Standard, Sulfadiazine, United States Pharmacopeia (USP) Reference Standard, Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material, 141582-64-1, Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard, Sulfazin, Sulfacombin, Soludiazine, Lantrisul, Sulfaloid, Suthogen, sulfadiazin-, Sulfonamide Duplex, Triple Sulfoid, Diazyl (VAN), Mixture Name, Sodium sulfadiazine, Sulfadiazine, Zinc, Neotrizine (TN), Solfadiazina sodica, Sulfadiazin-natrium, Sulfadiazina sodica, Lantrisul (TN), Sulfaloid (TN), Sulfa-Triple #2, Terfonyl (TN), Soluble sulfadiazine, Sulfadiazine sodique, Sulfose (TN), Sodium sulfapyrimidine, Sulfadiazinum natricum, Triple Sulfa (TN), Triple Sulfas (TN), Triple Sulfoid (TN), 2-Sulfanilamidopyridine, SULFADIAZINE SODIUM, Sulfonamides Duplex (TN), Sulfa-Triple #2 (TN), D05LKP, Solfadiazina sodica [DCIT], C10H10N4O2S.Na, UNII-84CS1P306F, component of Sulfonamide Duplex, Sulfonamide Duplex (Salt/Mix), Sulfadiazine sodium [USP:INN], Sulfadiazine sodium [USAN:INN], CID5215, Sulfadiazina sodica [INN-Spanish], Sulfadiazine sodique [INN-French], Monosodium 2-sulfanilamidopyrimidine, Sulfadiazinum natricum [INN-Latin], C10-H10-N4-O2-S.Na, EINECS 208-919-0, 2-Sulfanilamidopyrimidine sodium salt, AN-160, AR-1L4215, C10-H10-N4-O2-S, CS-O-02298, NSC 117870, Sulfadiazine, 99% - 100G 100g, Sulfanilamide, N1-2-pyrimidinyl-(8CI), A8527, Bencenosulfonamida, 4-amino-n-2-pirimidinil-, N1-2-Pyrimidinylsulfanilamide monosodium salt, Sodium, (N(sup 1)-2-pyrimidinylsulfanilamido)-, D013411, N(sup 1)-2-Pyrimidinylsulfanilamide monosodium salt, SDA, Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosodium salt, Mixture of sulfadiazine, sulfamerazine, and sulfamethazine, Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosodium salt, Adiazin;Adiazine;Debenal;Liquadiazine;Microsulfon;Sulfazine;Sulfolex, Bencenosulfonamida, 4-amino-N-2-pirimidinil-, sal de sodio (1:1), Sulfanilamide, N(sup 1)-2-pyrimidinyl-, N(sup 1)-sodium deriv, 116-44-9, SDZ, Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine, 547-32-0, 6938-59-6,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited